Xenon Pharmaceuticals (XENE) Tax Provisions (2018 - 2026)
Xenon Pharmaceuticals' (XENE) quarterly Tax Provisions came in at -$2.6 million in Q1 2026, down 702.11% year-on-year from $427000.0 in Q1 2025, and down 168.82% on a QoQ basis from $3.7 million in Q4 2025.
Xenon Pharmaceuticals (XENE) Tax Provisions (2018 - 2026) Analysis & Trends
Xenon Pharmaceuticals (XENE) has 9 years of Tax Provisions data on file, last reported at -$2.6 million in Q1 2026.
- On a quarterly basis, Tax Provisions fell 702.11% year-over-year to -$2.6 million in Q1 2026; TTM through Mar 2026 was $1.2 million, a 129.85% increase from a year earlier, with the FY2025 full-year figure at $4.2 million, up 203.06% from the prior year.
- Tax Provisions for Q1 2026 stood at -$2.6 million, down from $3.7 million in the prior quarter.
- Over the last five years, Tax Provisions for XENE reached as high as $3.7 million in Q4 2025 and fell as low as -$3.8 million in Q4 2024.
- Historically, Tax Provisions has averaged -$151529.4 across 5 years, with a median of -$205000.0 in 2023.
- Across the five-year window, Tax Provisions tumbled 1777.07% in 2024 and soared 311.56% in 2025, its largest moves.
- Year by year, Tax Provisions stood at $1.2 million in 2022, then sank by 117.33% to -$205000.0 in 2023, then tumbled by 1777.07% to -$3.8 million in 2024, then jumped by 197.09% to $3.7 million in 2025, then tumbled by 168.82% to -$2.6 million in 2026.
- Per Business Quant data, the three most recent Tax Provisions figures were -$2.6 million in Q1 2026, $3.7 million in Q4 2025, and $677000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 125,146.46 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -859,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 31.86 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 221.50 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -60.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Xenon Pharmaceuticals | 5.72 Bn | 5.72 Bn | - | -2.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.57 Mn |
| Dec 31, 2025 | 3.74 Mn |
| Sep 30, 2025 | 677,000.00 |
| Jun 30, 2025 | -626,000.00 |
| Mar 31, 2025 | 427,000.00 |
| Dec 31, 2024 | -3.85 Mn |
| Sep 30, 2024 | -320,000.00 |
| Jun 30, 2024 | -333,000.00 |
| Mar 31, 2024 | 412,000.00 |
| Dec 31, 2023 | -205,000.00 |
| Sep 30, 2023 | -157,000.00 |
| Jun 30, 2023 | -220,000.00 |
| Mar 31, 2023 | 290,000.00 |
| Dec 31, 2022 | 1.18 Mn |
| Sep 30, 2022 | -587,000.00 |
| Jun 30, 2022 | -40,000.00 |
| Mar 31, 2022 | -394,000.00 |
| Dec 31, 2021 | 2.52 Mn |
| Sep 30, 2021 | -205,000.00 |
| Jun 30, 2021 | -217,000.00 |